Drug Profile
PF 9404
Alternative Names: PF 9404CLatest Information Update: 05 Oct 2001
Price :
$50
*
At a glance
- Originator Almirall-Prodesfarma
- Class Ischaemic heart disorder therapies; Nitro compounds; Phenoxypropanolamines; Small molecules
- Mechanism of Action Beta-adrenergic receptor antagonists; Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Angina pectoris; Hypertension
Most Recent Events
- 05 Oct 2001 No-Development-Reported for Angina pectoris in Spain (Unknown route)
- 05 Oct 2001 No-Development-Reported for Hypertension in Spain (Unknown route)
- 06 Jul 2000 Preclinical development for Hypertension in Spain (Unknown route)